We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » State Treasurers Accuse Gilead of Seeking ‘Unreasonable Profits’ From Remdesivir
State Treasurers Accuse Gilead of Seeking ‘Unreasonable Profits’ From Remdesivir
In a letter to Gilead Sciences, almost a dozen state treasurers accused the company of seeking “unreasonable profits” from its antiviral COVID-19 treatment remdesivir, demanding that it lower the price.